Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal vs Oral Telapristone Distribution in Breast Tissue
NCT02314156Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 2015
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of telapristone in breast cancer (2 arms), sponsored by Northwestern University. Primary endpoint: Mean Levels of Telapristone Acetate in Breast Tissue at 4 weeks. Started Oct 2015; status: completed.
02
Drugs
telapristone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02314156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314156.